Sign inJoin waitlistJoin the waitlist

Dimitrios Colevas

Professor-Univ Med Line (By Courtesy), Otolaryngology · Stanford Health Care

Credentials: · · · ·

History

Stanford Health Care
Present
Stanford Health Care
Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
1992–1995
Internal Medicine
1989–1992
Johns Hopkins Univ Sch of Med
1985–1989

Research

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine · 2016 · 4,100 citations
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
Review · Seminars in Radiation Oncology · 2003 · 2,252 citations
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
New England Journal of Medicine · 2007 · 1,268 citations

MG
Maura Gillison
23 papers
Robert Haddad
23 papers
Vasu Divi
20 papers
MP
Marshall Posner
19 papers
Eben Rosenthal
18 papers
Michael Kaplan
17 papers
BM
Brock Martin
16 papers · 8 as a fellow
Harlan Pinto
16 papers
Jatin Shah
16 papers
Anthony Cmelak
14 papers
David Pfister
14 papers
John Sunwoo
14 papers

Clinical trials

Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma
Principal investigator · Completed · Phase 2
Stanford University
2017–2019
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
Principal investigator · Terminated · Phase 2
Stanford University
2013–2014
Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
Principal investigator · Completed · Phase 2
Stanford University
2008–2020
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029